Farallon Capital Partners, L.P. 13D/13G Filings for Tango Therapeutics, Inc. (TNGX)

Farallon Capital Partners, L.P. 13D and 13G filings for Tango Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-06
4:11 pm
Purchase
2025-12-3113GTANGO THERAPEUTICS INC
TNGX
Farallon Capital Partners, L.P.13,461,215
9.990%
13,461,215increase
(New Position)
Filing